Ernesto L. Schiffrin

57.3k total citations · 7 hit papers
567 papers, 39.0k citations indexed

About

Ernesto L. Schiffrin is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ernesto L. Schiffrin has authored 567 papers receiving a total of 39.0k indexed citations (citations by other indexed papers that have themselves been cited), including 307 papers in Cardiology and Cardiovascular Medicine, 196 papers in Physiology and 161 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ernesto L. Schiffrin's work include Nitric Oxide and Endothelin Effects (168 papers), Hormonal Regulation and Hypertension (148 papers) and Renin-Angiotensin System Studies (146 papers). Ernesto L. Schiffrin is often cited by papers focused on Nitric Oxide and Endothelin Effects (168 papers), Hormonal Regulation and Hypertension (148 papers) and Renin-Angiotensin System Studies (146 papers). Ernesto L. Schiffrin collaborates with scholars based in Canada, United States and United Kingdom. Ernesto L. Schiffrin's co-authors include Rhian M. Touyz, Hope D. Intengan, Pierre Paradis, Dierk Endemann, Farhad Amiri, Gaétan Thibault, Jacques Genest, Johannes F.E. Mann, Mário Fritsch Neves and Jeong Bae Park and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Circulation.

In The Last Decade

Ernesto L. Schiffrin

560 papers receiving 38.1k citations

Hit Papers

The Metabolic Syndrome and Cardiovascular Risk 2000 2026 2008 2017 2010 2007 2015 2004 2001 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Metabolic Syndrome and Cardiovascular Risk
    2010 2.1k citations Ernesto L. Schiffrin et al. profile →
  2. Chronic Kidney Disease
    2007 1.1k citations Ernesto L. Schiffrin et al. profile →
  3. Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness
    2015 1.0k citations Ernesto L. Schiffrin et al. Hypertension profile →
  4. Endothelial Dysfunction
    2004 947 citations Dierk Endemann, Ernesto L. Schiffrin profile →
  5. Vascular Remodeling in Hypertension
    2001 772 citations Ernesto L. Schiffrin et al. Hypertension profile →
  6. Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells
    2000 736 citations Rhian M. Touyz, Ernesto L. Schiffrin profile →
  7. Reactive oxygen species in vascular biology: implications in hypertension
    2004 508 citations Rhian M. Touyz, Ernesto L. Schiffrin profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ernesto L. Schiffrin Canada 101 18.9k 11.1k 10.4k 9.2k 5.5k 567 39.0k
Friedrich C. Luft Germany 112 16.9k 0.9× 8.8k 0.8× 9.1k 0.9× 12.8k 1.4× 6.8k 1.2× 1.1k 50.6k
Rhian M. Touyz Canada 104 12.6k 0.7× 9.2k 0.8× 7.5k 0.7× 11.0k 1.2× 4.5k 0.8× 522 37.0k
Joseph A. Vita United States 93 18.7k 1.0× 8.7k 0.8× 4.1k 0.4× 4.7k 0.5× 5.4k 1.0× 234 38.0k
James R. Sowers United States 95 15.6k 0.8× 8.7k 0.8× 14.8k 1.4× 10.0k 1.1× 6.4k 1.2× 689 42.7k
R. Wayne Alexander United States 92 14.1k 0.7× 8.6k 0.8× 5.2k 0.5× 11.2k 1.2× 5.3k 1.0× 198 35.4k
Mark E. Cooper Australia 109 12.7k 0.7× 5.4k 0.5× 17.9k 1.7× 11.6k 1.3× 5.9k 1.1× 514 48.8k
Kathy K. Griendling United States 95 12.9k 0.7× 17.1k 1.5× 5.8k 0.6× 17.0k 1.9× 4.1k 0.7× 231 46.1k
Suzanne Oparil United States 84 24.2k 1.3× 4.9k 0.4× 10.9k 1.0× 5.3k 0.6× 5.2k 1.0× 709 41.0k
David G. Harrison United States 134 20.4k 1.1× 23.3k 2.1× 7.3k 0.7× 14.1k 1.5× 7.3k 1.3× 400 60.5k
Akira Takeshita Japan 100 13.4k 0.7× 7.5k 0.7× 4.2k 0.4× 10.1k 1.1× 5.6k 1.0× 594 32.6k

Countries citing papers authored by Ernesto L. Schiffrin

Since Specialization
Citations

This map shows the geographic impact of Ernesto L. Schiffrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernesto L. Schiffrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernesto L. Schiffrin more than expected).

Fields of papers citing papers by Ernesto L. Schiffrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernesto L. Schiffrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernesto L. Schiffrin. The network helps show where Ernesto L. Schiffrin may publish in the future.

Co-authorship network of co-authors of Ernesto L. Schiffrin

This figure shows the co-authorship network connecting the top 25 collaborators of Ernesto L. Schiffrin. A scholar is included among the top collaborators of Ernesto L. Schiffrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernesto L. Schiffrin. Ernesto L. Schiffrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schiffrin, Ernesto L., et al.. (2025). Interplay Between the Mineralocorticoid System, Inflammation, Hypertension, and Kidney Disease. Kidney360. 6(11). 2017–2027.
2.
Alcocer, Luis, Ernesto L. Schiffrin, Gregory D. Fink, et al.. (2025). Racial and Gender Discrimination When Tailoring Medical Management to Hypertension Treatment in Latin America. American Journal of Hypertension. 38(10). 739–747.
3.
Berillo, Olga, Antoine Caillon, Séverine Leclerc, et al.. (2024). CD28-expressing δ T cells are increased in perivascular adipose tissue of hypertensive mice and in subcutaneous adipose tissue of obese humans. Journal of Hypertension. 42(7). 1256–1268. 4 indexed citations
4.
McFarlane, Phil, Mina Madan, Sheldon W. Tobe, et al.. (2024). Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Canada. Journal of Medical Economics. 28(1). 70–80. 1 indexed citations
5.
Cheung, Carol Y., Valérie Biousse, Pearse A. Keane, Ernesto L. Schiffrin, & Tien Yin Wong. (2022). Hypertensive eye disease. Nature Reviews Disease Primers. 8(1). 14–14. 54 indexed citations
6.
Higaki, Akinori, et al.. (2021). Automated Detection and Diameter Estimation for Mouse Mesenteric Artery Using Semantic Segmentation. Journal of Vascular Research. 58(6). 379–387. 1 indexed citations
7.
Barrera, Francisco J., Skand Shekhar, Forbes D. Porter, et al.. (2021). Scoping review of COVID-19-related systematic reviews and meta-analyses: can we really have confidence in their results?. Postgraduate Medical Journal. 98(1159). 372–379. 7 indexed citations
8.
Masi, Stefano, Damiano Rizzoni, Stefano Taddei, et al.. (2020). Assessment and pathophysiology of microvascular disease: recent progress and clinical implications. European Heart Journal. 42(26). 2590–2604. 93 indexed citations
9.
Higaki, Akinori, et al.. (2020). Role of interleukin-23/interleukin-17 axis in T-cell-mediated actions in hypertension. Cardiovascular Research. 117(5). 1274–1283. 31 indexed citations
10.
Paradis, Pierre, et al.. (2020). Human and murine memory γδ T cells: Evidence for acquired immune memory in bacterial and viral infections and autoimmunity. Cellular Immunology. 357. 104217–104217. 27 indexed citations
11.
Marchesi, Chiara, Asia Rehman, Yohann Rautureau, et al.. (2012). Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease. Cardiovascular Research. 97(3). 562–570. 46 indexed citations
12.
Schiffrin, Ernesto L.. (2011). Immune Modulation of Resistance Artery Remodelling. Basic & Clinical Pharmacology & Toxicology. 110(1). 70–72. 16 indexed citations
13.
Savoia, Carmine, Rhian M. Touyz, Massimo Volpe, & Ernesto L. Schiffrin. (2006). Angiotensin Type 2 Receptor in Resistance Arteries of Type 2 Diabetic Hypertensive Patients. Hypertension. 49(2). 341–346. 103 indexed citations
14.
Touyz, Rhian M. & Ernesto L. Schiffrin. (2006). Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. Vascular Pharmacology. 45(1). 19–28. 124 indexed citations
15.
Averill, David B., et al.. (2005). Role of Blood Pressure Reduction in Prevention of Cardiac and Vascular Hypertrophy. American Journal of Hypertension. 18(7). 922–929. 29 indexed citations
16.
Endemann, Dierk, Rhian M. Touyz, Marc Iglarz, Carmine Savoia, & Ernesto L. Schiffrin. (2004). Eplerenone Prevents Salt-Induced Vascular Remodeling and Cardiac Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats. Hypertension. 43(6). 1252–1257. 94 indexed citations
17.
Virdis, Agostino, Mário Fritsch Neves, Farhad Amiri, Rhian M. Touyz, & Ernesto L. Schiffrin. (2004). Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. Journal of Hypertension. 22(3). 535–542. 202 indexed citations
18.
Touyz, Rhian M., Xin Chen, Jeong Bae Park, & Ernesto L. Schiffrin. (2000). Attenuated Development of Hypertension by Antioxidant Vitamins in Stroke-Prone Shr Is Associated with Increased Vascular Superoxide Dismutase Activity and Decreased Oxidative Stress.. Hypertension. 36. 699–699. 1 indexed citations
19.
Park, Jeong Bae & Ernesto L. Schiffrin. (2000). Eta Receptor Antagonist Prevents Blood Pressure Elevation and Vascular Hypertrophy of Resistance Arteries in Aldosterone-Infused Rats.. Hypertension. 36. 724–724. 1 indexed citations
20.
Schiffrin, Ernesto L., et al.. (1992). Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients. Journal of Hypertension. 10(5). 437–444. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Friedrich C. Luft Breakdown of academic impact, for papers by Rhian M. Touyz Breakdown of academic impact, for papers by Joseph A. Vita Breakdown of academic impact, for papers by James R. Sowers Breakdown of academic impact, for papers by R. Wayne Alexander Breakdown of academic impact, for papers by Mark E. Cooper Breakdown of academic impact, for papers by Kathy K. Griendling Breakdown of academic impact, for papers by Suzanne Oparil Breakdown of academic impact, for papers by David G. Harrison Breakdown of academic impact, for papers by Akira Takeshita
Rankless by CCL
2026